Copper Electropolishing in Concentrated Phosphoric Acid: II . Theoretical Interpretation

1995 ◽  
Vol 142 (8) ◽  
pp. 2689-2694 ◽  
Author(s):  
Roberto Vidal ◽  
Alan C. West
Keyword(s):  
Phosphoric Acid ◽  
Theoretical Interpretation ◽  
Copper Electropolishing

A Mechanistic Model for Copper Electropolishing in Phosphoric Acid

2008 ◽  
Vol 155 (1) ◽  
pp. D27 ◽  
Author(s):  
Julie Mendez ◽  
Rohan Akolkar ◽  
Tatyana Andryushchenko ◽  
Uziel Landau
Keyword(s):  
Phosphoric Acid ◽  
Mechanistic Model ◽  
Copper Electropolishing

The concerted use of SEM, TEM, and SCM for examination of resin-dentin interfaces

1994 ◽  
Vol 52 ◽  
pp. 476-477
Author(s):  
B. Van Meerbeek ◽  
L. J. Conn ◽  
E. S. Duke
Keyword(s):  
Surface Layer ◽  
Stress Distribution ◽  
Phosphoric Acid ◽  
Bonding Mechanism ◽  
Restorative Dentistry ◽  
Dental Adhesive ◽  
Low Viscosity ◽  
Dentin Adhesives ◽  
Acid Etch ◽  
Tooth Tissue

Restoration of decayed teeth with tooth-colored materials that can be bonded to tooth tissue has been a highly desirable property in restorative dentistry for many years. Advantages of such an adhesive restorative technique over conventional techniques using non-adhesive metal-based restoratives include improved restoration retention with minimal sacrifice of sound tooth tissue for retention purposes, superior adaptation and sealing of the restoration margins in prevention of caries recurrence, improved stress distribution across the tooth-restoration interface throughout the whole tooth, and even reinforcement of weakened tooth structures. The dental adhesive technology is rapidly changing. An efficient resin bond to enamel has already long been achieved. Its bonding mechanism has been fully elucidated and has proven to be a durable and reliable clinical treatment. However, bonding to dentin represents a greater challenge. After the failures of a dentin acid-etch technique in imitation of the enamel phosphoric-acid-etch technique and a bonding procedure based on chemical adhesion, modern dentin adhesives are currently believed to bond to dentin by a micromechanical hybridization process. This process is developed by an initial demineralization of the dentin surface layer with acid etchants exposing a collagen fibril arrangement with interfibrillar microporosities that subsequently become impregnated by low-viscosity monomers. Although the development of such a hybridization process has well been documented in the literature, questions remain with respect to parameters of-primary importance to adhesive efficacy.

Phosphoric Acid from Slags

1884 ◽  
Vol 18 (457supp) ◽  
pp. 7298-7298
Author(s):  
C. Scheibler
Keyword(s):  
Phosphoric Acid

MOTIONS IN A VISCOUS INORGANIC LIQUID : FERROUS ION IN COLD PHOSPHORIC ACID

1976 ◽  
Vol 37 (C6) ◽  
pp. C6-739-C6-743 ◽  
Author(s):  
P. A. FLINN ◽  
B. J. ZABRANSKY ◽  
S. L. RUBY
Keyword(s):  
Phosphoric Acid ◽  
Ferrous Ion

CLINICAL INVESTIGATIONS OF A LONG-ACTING OESTRIOL (POLYOESTRIOL PHOSPHATE)

1961 ◽  
Vol 38 (1) ◽  
pp. 73-87 ◽  
Author(s):  
Christian Lauritzen ◽  
Semih Velibese
Keyword(s):  
Side Effects ◽  
Phosphoric Acid ◽  
Quantitative Data ◽  
Water Soluble ◽  
Cholesterol Concentration ◽  
Experimental Investigations ◽  
Clinical Investigations ◽  
Prolonged Duration ◽  
High Doses ◽  
Long Acting

ABSTRACT A description is given of experimental investigations and preliminary clinical experience with the long-acting oestriol compound polyoestriol phosphate – a water-soluble polymere of oestriol and phosphoric acid. The compound seems to exert all the physiologically important effects of oestriol. Even with high doses the hormone causes no proliferation of the endometrium and no withdrawal bleeding. It has no untoward effect on metabolism. It decreases slightly the cholesterol concentration (to the extent of ⅓–⅕ of the effect produced by long-acting oestradiol esters). The compound has a wide therapeutic range. No side-effects have been observed. Doses of 10 mg or more have a prolonged duration. Additional prolongation of the effect is largely dependent on dosage. To ensure an effect lasting for 4 weeks 40 mg polyoestriol phosphate (corresponding with 30 mg oestriol) is required – an amount which roughly corresponds with physiological quantitative data. The compound, which involves an interesting new principle of prolongation, was most effectively used in the treatment of menopausal symptoms and genital organic disorders. For these indications it can be recommended without reservation.

Sign in / Sign up

Export Citation Format

Share Document